NovaBridge Biosciences (NBP) EBT Growth (1y) (2020 - 2025)
NovaBridge Biosciences (NBP) EBT Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
-79.57% |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
-313.33% |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
NovaBridge Biosciences |
323.78 Mn |
112.94 Mn |
- |
-571.87% |
| Date | Value |
|---|
| Dec 31, 2025 |
-571.87% |
| Sep 30, 2025 |
66.68% |
| Jun 30, 2025 |
38.45% |
| Mar 31, 2025 |
66.56% |
| Dec 31, 2024 |
70.62% |
| Sep 30, 2024 |
-149.25% |
| Jun 30, 2024 |
67.55% |
| Dec 31, 2020 |
421.52% |
| Sep 30, 2020 |
-134.63% |
